Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKooth Plc Regulatory News (KOO)

Share Price Information for Kooth Plc (KOO)

Share Price is delayed by 15 minutes
Get Live Data
162.50    -5.50 (-3.27%)
Bid:
160.00
Ask:
165.00
Spread: 5.00 (3.125%)
Market Cap: £58.94m
KOO Live PriceLast checked at - London Stock Exchange

Intraday Kooth Plc Share Chart

Trading Statement

20 Jan 2022 07:00

RNS Number : 0123Z
Kooth PLC
20 January 2022
 

20 January 2022

 

Kooth plc

("Kooth" or the "Group")

Trading update & Board Appointment

Strong revenue growth; performance in line with expectations

Kooth, the UK's leading digital mental health platform, announces a trading update for the financial year ended 31 December 2021.

Revenue is expected to be in line with market expectations, supported by strong growth of more than 25%.

Kooth will provide further details in its full year results, which are expected to be announced in March 2022.

Unaudited net cash at year end was £7.0m and the Group remains debt free.

During the year, Kooth continued to strengthen the breadth and depth of its leadership team. We are delighted to announce the appointment of Kate Newhouse to the Board of Kooth plc. Kate will continue in her role as Chief Operating Officer, having joined Kooth in May 2020 with a wealth of leadership experience in the digital health space. Kate was previously CEO of Doctor Care Anywhere and CEO of Blenheim Chalcot.

This follows the appointment of Dr Tim Budden as Chief Technical Officer. During the period, Kooth made preliminary steps relating to its US operations with the hiring of Kevin Winters as General Manager - North America. Kevin brings US digital mental health experience, gained from SilverCloud Health, and also spent more than 14 years at Cerner Corporation working with numerous global healthcare bodies and payors. At Kooth, Kevin will focus on establishing Kooth's US service, especially supporting Children and Young People via healthcare and education.

Tim Barker, Chief Executive Officer of Kooth, said:

"Kooth's mission is to make effective, personalised digital mental health care available to all. Our excellent performance in 2021 reflects increasing demand for our platform and progress with this simple, clear mission. I am delighted to report strong revenue growth and performance in line with market expectations. Kooth is expanding support to Adults via the NHS and Corporates, building on its leadership position with children and young people via the NHS, in addition to having recently made its first senior hire in the US.

"Kooth has a robust balance sheet which supports further investment in people and technology to meet our scaling ambitions. We look forward to further progress in 2022."

Kate Newhouse (previously Wigley), aged 40, does not currently hold any directorships and was a director of Doctor Care Anywhere Limited and Kate Newhouse Consulting Ltd in the previous five years.

Kate holds 480,966 ordinary shares in the Group, equivalent to 1.5% of the Group's current issued share capital.

There is no further information required to be disclosed under Rule 17 or paragraph (g) of Schedule 2 of the AIM Rules for Companies.

 

ENDS 

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 ('MAR'). Upon the publication of this announcement via a Regulatory Information Service ('RIS'), this inside information is now considered to be in the public domain.

 

Enquiries:

Kooth plc

investorrelations@kooth.com

Tim Barker, CEO

Sanjay Jawa, CFO

Panmure Gordon, Nominated Adviser and Joint Broker

 

Corporate Finance:

Dominic Morley, Ailsa MacMaster

+44 (0) 20 7886 2500

 

Corporate Broking:

Erik Anderson

Stifel, Joint Broker

+44 (0) 20 7710 7600

Ben Maddison, Nick Adams, Nicholas Harland

FTI Consulting

kooth@fticonsulting.com

Jamie Ricketts, Alex Shaw, Usama Ali

 

About Kooth plc:

 

Kooth (AIM:KOO) is the UK's leading digital mental health platform. Our mission is to provide accessible and safe spaces for everyone to achieve better mental health. Our platform is clinically robust and accredited to provide a range of therapeutic support and interventions. All our services are predicated on easy access to make early intervention and prevention a reality.

 

Our four services are:

 

· Kooth: for children and young persons

· Kooth Student: for university and higher-education students

· Kooth: for Adults

· Kooth Work: for employees

 

Kooth is a fully safeguarded and pre-moderated community with a library of peer and professional created content, alongside access to experienced online counsellors. There are no thresholds for support and no waiting lists. Currently, Kooth sees over 4,000 logins a day.

 

For adults, Kooth operates across distinct locations and serves specific cohorts, including parents, teachers, victims of crime, and those who have suffered from or continue to experience domestic violence. It is also offered as a benefit by a number of corporate organisations delivering anonymous digital mental health support services to employees.

 

Kooth is the only digital mental health provider to hold a UK-wide accreditation from the British Association of Counselling and Psychotherapy (BACP).

 

In 2021, Kooth was named 'Best Newcomer' at the European Mediscience Awards, winner in the category of 'Tech for Good' at the UK Tech Awards and recognised as the 'HealthTech Pioneer of the Year' at the UK Business Tech Awards for its role in 'Supporting the Nation's Mental Health'.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBRGDBRSBDGDC
Date   Source Headline
19th May 20267:00 amRNS2025 Annual Report and Notice of 2026 AGM
19th May 20267:00 amRNSDirectorate Change
20th Apr 20267:00 amRNS-R2025 Impact Report Shows Soluna's Continued Growth
8th Apr 20267:00 amRNS2025 Full Year Results
19th Mar 20267:00 amRNSNotice of Full Year Results
12th Mar 20269:19 amRNSTransfer of Treasury Shares & Exercise of Options
2nd Mar 202610:57 amRNSTransfer of Treasury Shares & Exercise of Options
2nd Mar 20267:00 amRNSBlock Listing Six Monthly Return
11th Feb 20265:51 pmRNSAwards under LTIP and PDMR dealing
2nd Feb 202612:48 pmRNSTransfer of Treasury Shares & Exercise of Options
28th Jan 20267:00 amRNSTrading Update
22nd Jan 20267:05 amRNSHolding(s) in Company
22nd Jan 20267:00 amRNS$2.6m contract win with new US State
17th Dec 202510:02 amRNSTransfer of Treasury Shares & Exercise of Options
4th Dec 20253:26 pmRNSHolding(s) in Company
19th Nov 20257:00 amRNS-RKooth Acquires US Telehealth Platform
11th Nov 20257:00 amRNSTransfer of Treasury Shares & Exercise of Options
10th Oct 20252:30 pmRNSHolding(s) in Company
2nd Oct 20257:00 amRNSKooth renews New Jersey contract
24th Sep 20253:55 pmRNSHolding(s) in Company
23rd Sep 20257:00 amRNSUnaudited Half Year Results
4th Sep 20257:00 amRNSTransfer of Treasury Shares & Exercise of Options
29th Aug 20257:00 amRNSBlock Listing Six Monthly Return
8th Aug 20257:00 amRNSAppointment of Joint Corporate Broker
1st Aug 20257:00 amRNSTransfer of Treasury Shares & Exercise of Options
28th Jul 20257:00 amRNSHalf Year Trading and Operational Update
1st Jul 20257:00 amRNSKooth welcomes report on California Soluna data
27th Jun 20253:51 pmRNSHolding(s) in Company
24th Jun 20251:12 pmRNSResult of 2025 Annual General Meeting
3rd Jun 20259:32 amRNSHolding(s) in Company
23rd May 20254:06 pmRNSAwards - Long Term Incentive Plan and PDMR dealing
14th May 20257:00 amRNSAnnual Financial Report
15th Apr 20257:00 amRNSFull Year Results
31st Mar 20251:00 pmRNSHolding in Company
28th Feb 20257:00 amRNSBlock Listing Six Monthly Return
13th Feb 20257:00 amRNSTransaction in Own Shares
12th Feb 20257:00 amRNSTransaction in Own Shares
11th Feb 20257:00 amRNSTransaction in Own Shares
10th Feb 20257:00 amRNSTransaction in Own Shares
7th Feb 20257:00 amRNSTransaction in Own Shares
6th Feb 20257:00 amRNSTransaction in Own Shares
5th Feb 20255:53 pmRNSHolding(s) in Company
5th Feb 20257:00 amRNSTransaction in Own Shares
4th Feb 20257:00 amRNSTransaction in Own Shares
3rd Feb 20257:00 amRNSTransaction in Own Shares
31st Jan 20257:00 amRNSTransaction in Own Shares
30th Jan 20257:00 amRNSTransaction in Own Shares
29th Jan 20257:00 amRNSTransaction in Own Shares
28th Jan 20257:00 amRNSTransaction in Own Shares
27th Jan 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.